AstraZeneca Launches Calquence in China for Mantle Cell Lymphoma Treatment
UK-based pharmaceutical giant AstraZeneca (AZ, NASDAQ: AZN) has announced the official market launch of Calquence...
Kangtai Biological Partners with Indian Pharmaceutical Giant for 13-Valent Pneumonia Vaccine
Shenzhen Kangtai Biological Products Co., Ltd (SHE: 300601), a leading Chinese biopharmaceutical company, has entered...
Medtronic Launches AiBLE Orthopedic Ecosystem and Partners with Allinmd Orthopedics in China
US-based Medtronic Inc., (NYSE: MDT) has launched AiBLE, an innovative ecological ecosystem concept for orthopedics,...
TYK Medicines Partners with WuXi STA for Comprehensive CMC Services
Shanghai-based TYK Medicines has announced a partnership with WuXi STA, a subsidiary of WuXi AppTec...
Beijing’s E-Health Now Secures Tens of Millions in Series B Financing
E-Health Now, a comprehensive health management platform headquartered in Beijing, has reportedly raised tens of...
Boyi Biotech Secures Over RMB100 Million in Series A Financing Led by JOLMO
Boyi Biotech, a prominent biological microspheres developer headquartered in Changzhou, has reportedly secured more than...
Mindray Partners with Vazyme Biotech to Develop Automated Infection Screening Solutions
China-based medical device company Mindray (SHE: 300760) has entered into a partnership with fellow Chinese...
Hisun Pharmaceutical’s SHP2 Inhibitor HS336 Gets NMPA Clinical Trial Approval
Zhejiang Hisun Pharmaceutical Co., Ltd (SHA: 600267), a China-based pharmaceutical company, has announced that it...
Hainan Boao Lecheng Introduces 319 Overseas Drugs and Devices, Reports Significant Growth
The Hainan Boao Lecheng International Medical Tourism Pilot Zone has introduced 319 clinically urgently needed...
Moderna Establishes USD 100 Million Subsidiary in Shanghai to Expand mRNA Technology
US-based vaccine manufacturer Moderna (NASDAQ: MRNA) has registered a new subsidiary in the Minhang district...
Hubei Leads National Volume-Based Procurement of Patented Traditional Chinese Medicines
The Healthcare Security Administration (HSA) bureau of Hubei province has released a notification outlining plans...
Harbour Biomed’s Porustobart Combo Shows Promise in HCC Treatment, ASCO Presentation Reveals
China-based Harbour Biomed (HKG: 2142) has announced the publication of results from a Phase Ib...
Ascentage Pharma’s Olverembatinib Earns Breakthrough Designation for SDH-Deficient GIST
The China’s Center for Drug Evaluation (CDE) has granted breakthrough therapy designation (BTD) to olverembatinib,...
Abbisko Therapeutics Reports Positive Phase Ib Results for ABSK021 at ASCO
Shanghai-based biotech Abbisko Therapeutics Co., Ltd (HKG: 2256) is poised to announce positive results from...
Shanghai Yizhong’s Paclitaxel Micelles Data to be Presented at ASCO Annual Meeting
Shanghai Yizhong Pharmaceutical Co., Ltd (SHA: 688091), a China-based pharmaceutical company, has announced that clinical...
SAMR Imposes Penalties on Grand Pharma and WuHan Huihai for Monopoly Agreements
The State Administration for Market Regulation (SAMR) has imposed administrative penalties on Grand Pharmaceutical Group...
Ascentage Pharma to Present Clinical Results of Four Oncology Drugs at Medical Conference
Suzhou-based Ascentage Pharma (HKG: 6855) has announced its intention to present the clinical results of...
Hainan Province and NHSA Partner to Enhance Medical Insurance Industry with Real-World Data
The government of Hainan province has entered into a strategic partnership with the National Healthcare...
BeiGene Presents Groundbreaking Clinical Data at ASCO Annual Meeting
China-based BeiGene (NASDAQ: BGNE, HKG: 6160, SHA: 688235) announced the presentation of new data at...
Shanghai Market Regulation Bureau Targets Unfair Competition in Pharmaceutical Sector
The Shanghai market regulation bureau has released a document aimed at cracking down on unfair...